Moses Lake Pharmacy Recalls Methylcobalamin Injectable Solution for Sterility Concerns
JD & SN Inc. is recalling Methylcobalamin MDV Injectable Solution due to a lack of assurance of sterility. The recall covers all sterile human compounded drugs within their expiry dates.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a risk of serious infection or injury, meeting the criteria for a Severe rating.
Plain-English summary
JD & SN Inc., doing business as Moses Lake Professional Pharmacy, is recalling Methylcobalamin MDV Injectable Solution, 2 MG/ML, 10mL syringes. The recall was initiated because of a lack of assurance of sterility. The affected product is a prescription-only injectable solution.
The recall applies to all sterile human compounded drugs within their expiry dates. The source text does not specify the exact number of units recalled or the specific distribution locations, though the product is identified as being from a pharmacy in Moses Lake, Washington.
Consumers and healthcare providers should stop using the affected product and contact the recalling firm or their healthcare provider for further instructions. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- METHYLCOBALAMIN MDV, Injectable Solution, 2 MG/ML, 10mL syringe; Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Injectable Solution
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- t06042015@22
- t01202015@4
- t05082015@5
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereRXQ Compounding Recalls Methylcobalamin Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SeverePharm D Solutions Recalls Methylcobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SevereRed Mountain Compounding Recalls S-Methylcobalamin Injections for Sterility Concerns
FDA (Drugs) · 2019-11-13
- SevereMethylcobalamin Injectable: Sterility Assurance Deficiency
FDA (Drugs) · 2021-11-03
- ModerateMethylcobalamin injection recalled due to sterility assurance concerns
FDA (Drugs) · 2021-11-03
- SeverePromise Pharmacy Recalls Methylcobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-02-20